Treatment & Vaccine

Does India have a vaccine distribution plan?

Does India Have a Vaccine Distribution Plan? Experts Answer

‘Don’t Go By Efficacy, Oxford Vaccine is the Best News for India’

Oxford COVID-19 Vaccine: Why larger coverage matters more than efficacy.

60-70% of Population Needs to be Immune to Stop COVID Transmission

University’s Center for Systems Science and Engineering (CSSE) revealed that the current global caseload and death toll stood at 61,585,651 and 1,441,875

Russia & Hetero to Produce 100M Sputnik V Vaccine Doses in India

“We are pleased to collaborate with RDIF as a manufacturing partner for the most anticipated Sputnik V vaccine for the treatment of Covid-19.”

Oxford AstraZeneca May Order Fresh Trials: What Went Wrong?

A large-scale Phase 3 trial of the COVID-19 vaccine candidate being developed jointly by AstraZeneca and the University of Oxford may require fresh trials.

Vaccines Will Be Available for the Public Only by Mid-2021: Report

Vaccine availability will vary across countries.

Russia's Sputnik V vaccine has been found to be more than 95 per cent effective against Covid-19 in the second interim analysis.

Russia's Sputnik Vaccine 95% Effective Reveals Second Interim Data

Here’s Why the Oxford COVID-19 Vaccine is the Best Bet for India

COVID Vaccine FAQ: What We Know About Bharat Biotech’s ‘Covaxin’

The company has not shared the results from its phase 1, 2 or preclinical trials either.

Bharat Biotech Says Covaxin at Least 60% Effective; No Data Shared

MMR Vaccine May Protect Against COVID-19: Study 

Indian-American Scientists Identify Possible COVID-19 Treatment 

Does India have a vaccine distribution plan?

Does India Have a Vaccine Distribution Plan? Experts Answer

‘Don’t Go By Efficacy, Oxford Vaccine is the Best News for India’

Oxford COVID-19 Vaccine: Why larger coverage matters more than efficacy.

60-70% of Population Needs to be Immune to Stop COVID Transmission

University’s Center for Systems Science and Engineering (CSSE) revealed that the current global caseload and death toll stood at 61,585,651 and 1,441,875
“We are pleased to collaborate with RDIF as a manufacturing partner for the most anticipated Sputnik V vaccine for the treatment of Covid-19.”

Russia & Hetero to Produce 100M Sputnik V Vaccine Doses in India

Oxford AstraZeneca May Order Fresh Trials: What Went Wrong?

A large-scale Phase 3 trial of the COVID-19 vaccine candidate being developed jointly by AstraZeneca and the University of Oxford may require fresh trials.

Vaccines Will Be Available for the Public Only by Mid-2021: Report

Vaccine availability will vary across countries.
Russia's Sputnik V vaccine has been found to be more than 95 per cent effective against Covid-19 in the second interim analysis.

Russia's Sputnik Vaccine 95% Effective Reveals Second Interim Data

Here’s Why the Oxford COVID-19 Vaccine is the Best Bet for India

Oxford AstraZeneca vaccine has 70.4 percent efficacy, meaning it can prevent 70.4% people from getting COVID-19, according to newly released data.

COVID Vaccine FAQ: What We Know About Bharat Biotech’s ‘Covaxin’

When will it be available? How much will Covaxin cost? Do we know enough about its efficacy and safety yet?
The company has not shared the results from its phase 1, 2 or preclinical trials either.

Bharat Biotech Says Covaxin at Least 60% Effective; No Data Shared

MMR Vaccine May Protect Against COVID-19: Study 

Scientists have now claimed that MMR vaccine which protects against measles, mumps and rubella, may also protect some people against severe Covid-19 symptoms.

Indian-American Scientists Identify Possible COVID-19 Treatment 

Researchers have discovered a potential strategy to prevent life-threatening inflammation, lung damage and organ failure in patients with Covid-19.